|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Rat JAM2 ORF mammalian expression plasmid, C-GFPSpark tag||RG80376-ACG|
|Rat JAM2 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||RG80376-ACR|
|Rat JAM2 ORF mammalian expression plasmid, C-Flag tag||RG80376-CF|
|Rat JAM2 ORF mammalian expression plasmid, C-His tag||RG80376-CH|
|Rat JAM2 ORF mammalian expression plasmid, C-Myc tag||RG80376-CM|
|Rat JAM2 ORF mammalian expression plasmid, C-HA tag||RG80376-CY|
|Rat JAM2 Gene cDNA clone plasmid||RG80376-G|
|Rat JAM2 ORF mammalian expression plasmid, N-Flag tag||RG80376-NF|
|Rat JAM2 ORF mammalian expression plasmid, N-His tag||RG80376-NH|
|Rat JAM2 ORF mammalian expression plasmid, N-Myc tag||RG80376-NM|
|Rat JAM2 ORF mammalian expression plasmid, N-HA tag||RG80376-NY|
|Rat JAM2 natural ORF mammalian expression plasmid||RG80376-UT|
|Learn more about expression Vectors|
Junctional adhesion molecule B (JAM-B), also known as Junctional adhesion molecule 2 (JAM2), Vascular endothelial junction-associated molecule (VE-JAM), and CD322, is a single-pass type I membrane protein which belongs to the immunoglobulin superfamily. It is prominently expressed on high endothelial venules. expression to be restricted to the high endothelial venule of tonsil and lymph nodes. The localization to the endothelium of arterioles in and around inflammatory and tumor foci. JAM-B can function as an adhesive ligand for the T cell line J45 and can interact with GM-CSF/IL-4-derived peripheral blood dendritic cells, circulating CD56(+) NK cells, circulating CD56(+)CD3(+) NK/T cells, and circulating CD56(+)CD3(+)CD8(+) cytolytic T cells. JAM-2 is expressed on high endothelial venules (HEVs) in human tonsil and on a subset of human leukocytes, suggesting that JAM-2 plays a central role in the regulation of transendothelial migration. It binds to very late activation antigen (VLA)-4, a leucocyte integrin that contributes to rolling and firm adhesion of lymphocytes to endothelial cells through binding to vascular cell adhesion molecule (VCAM)-1. JAM-B appears to contribute to leucocyte extravasation by facilitating not only transmigration but also rolling and adhesion. JAM-B acts as an adhesive ligand for interacting with a variety of immune cell types and may play a role in lymphocyte homing to secondary lymphoid organs.